Mice with podocyte-specific overexpression of wild type α-actinin-4 are healthy controls for K256E-α-actinin-4 mutant transgenic mice
- First Online:
- Cite this article as:
- Michaud, JL., Stitt-Cavanaugh, E., Endlich, N. et al. Transgenic Res (2010) 19: 285. doi:10.1007/s11248-009-9305-9
- 164 Downloads
Mutations in the gene ACTN4 encoding the actin bundling protein—α-actinin-4 underlie an inherited form of kidney lesions known as focal segmental glomerulosclerosis (FSGS). Previously, we developed a model for this condition by generating mice with podocyte-specific overexpression of a disease-causing mutant α-actinin-4 (K256E-ACTN4pod+). However, whether α-actinin-4 overexpression artifacts and not the gain of affinity effects of the mutation accounted for the robust FSGS phenotype in these mice was unclear. To address this question, we developed a control line of mice with podocyte-specific overexpression of wildtype α-actinin-4 (wt-ACTN4pod+). An 8.3 kb fragment of the mouse nephrin promoter (NPHS1) was used to drive expression of a hemagglutinin (HA)-tagged wildtype α-actinin-4 coding sequence in mice. Five founder lines expressing the HA-tagged α-actinin-4 protein in a podocyte-specific manner were obtained, as determined by co-immunofluorescence with HA and synaptopodin antibodies. Quantitative PCR revealed that renal transgene mRNA levels of wt-ACTN4pod+ mice are similar to K256E-ACTN4pod+ mice. In contrast to K256E-ACTN4pod+ mice which exhibit albuminuria, podocyte foot process effacement and glomerular scarring, wt-ACTN4pod+ mice are healthy and indistinguishable from non-transgenic littermates. These findings suggest that the K256E mutation itself and not overexpression of α-actinin-4 protein per se accounts for the FSGS phenotype in our transgenic model.